Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has ...

Cold Spring Harbor Laboratory (CSHL) scientists have developed a new model for assessing kidney function in cancer patients as part of an international collaboration that involved contributions from ...

The MarketWatch News Department was not involved in the creation of this content. -- Real-World Implementation: Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in ...

Living kidney donation necessitates rigorous pre‐donation evaluation to ensure donor safety and optimise postoperative outcomes. A critical component in this process is the accurate assessment of ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has ...

An expert task force on Thursday released a new and much-anticipated approach for diagnosing kidney function, saying there is no need for controversial algorithms that consider race in the assessment ...

PITTSBURGH, Aug. 13, 2021 – An accurate assessment of a patient’s kidney function is critical for determining eligibility for anticancer treatments. In a paper published today in The Lancet Oncology, ...

Please provide your email address to receive an email when new articles are posted on . A joint task force of the National Kidney Foundation and the American Society of Nephrology has released its ...